OGN logo

Organon & Co. (OGN)

Profile

Full Name

Organon & Co.

Ticker

NYSE: OGN

Exchange

NYSE

Sector

Healthcare

Industry

General Drug Manufacturers

Country

United States

IPO

May 14, 2021

Indexes

Not included

Website

https://www.organon.com

Employees

10000

Key Details

Price

$7.74(3.06%)

Market Cap

$2.01B(Mid cap)

Last Dividend

$0.02

TTM Dividend Yield

4.39%

Annual Revenue

$6.40B(2.24% YoY)

Annual EPS

$3.33(-16.48% YoY)

PE Ratio

4.02

Next earnings date

Feb 12, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.74
    OGN price is $7.74

    30-Day Relative Volume

    0.61
    OGN 30-day relative volume is 0.61

    Price Performance

    Price Most Recent Change

    +3.06%
    OGN price was up +3.06% on Nov 26, 2025

    Price YTD Change

    -48.12%
    OGN price is down -48.12% since January 1st

    Price 1-Year Change

    -51.56%
    OGN price is down -51.56% year-on-year

    Price 3-Year Change

    -68.61%
    OGN price is down -68.61% over the past 3 years

    Price Range

    Price All-Time High

    $39.48
    OGN price is currently -80.39% below its historical high of $39.48

    Price 3-Year Low

    $6.18
    OGN price is currently +25.24% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $2.01B
    OGN market cap is $2.01 billion

    Market Cap 3-Year Change

    -67.92%
    OGN market cap is down -67.92% over the past 3 years

    Market Cap All-Time High

    $9.98B
    OGN market cap is currently -79.84% below its historical high of $9.98 billion

    Market Cap Sector Percentile

    79.49%
    OGN market cap is higher than 79.49% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.95%
    OGN shares outstanding is up +0.95% year-on-year

    Shares Outstanding 3-Year Change

    +2.21%
    OGN shares outstanding is up +2.21% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.91
    OGN beta is 0.91

    200-day SMA

    $10.55
    OGN price is currently -26.64% below its 200-day simple moving average

    50-day SMA

    $8.70
    OGN price is currently -11.06% below its 50-day simple moving average

    14-Day RSI

    50.29
    OGN 14-day relative strength index is 50.29

    Volume

    0.61
    OGN 30-day relative volume is 0.61

    ATR

    $0.42
    OGN average true range is $0.42

    10-day Historical Volatility

    50.29%
    OGN 10-day historical volatility is 50.29%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.02
    OGN last dividend was $0.02 per share, with an ex-dividend date of November 20, 2025

    Next Dividend

    -
    OGN next dividend has not yet been announced

    Dividend per share

    Dividend Per Share

    $1.12
    OGN annual dividend per share is $1.12

    Dividend Per Share Sector Percentile

    49.4%
    OGN annual dividend per share is higher than 49.4% of companies in Healthcare sector

    Dividend Per Share 1-Year Change

    0%
    OGN annual dividend per share has remained unchanged year-on-year

    Dividend Per Share 3-Year Change

    +100%
    OGN annual dividend per share is up +100% over the past 3 years

    Dividend yield

    Dividend Yield

    14.47%
    OGN annual dividend yield is 14.47%

    Dividend Yield Sector Percentile

    96.34%
    OGN annual dividend yield is higher than 96.34% of companies in Healthcare sector

    Other

    Payout Ratio

    34.38%
    OGN annual payout ratio is 34.38%

    Dividends Paid

    $297.00M
    OGN annual dividends paid is $297.00 million

    Free Cash Flow

    $693.00M
    OGN annual free cash flow is $693.00 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $6.40B
    OGN annual revenue is $6.40 billion

    Revenue Analysts Estimate

    $6.23B
    OGN annual revenue is currently +2.71% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    +2.24%
    OGN annual revenue is up +2.24% year-on-year

    Revenue Sector Percentile

    94.75%
    OGN annual revenue is higher than 94.75% of companies in Healthcare sector

    EPS

    EPS

    $3.33
    OGN annual earnings per share is $3.33

    EPS Analysts Estimate

    $3.76
    OGN annual earnings per share is currently -11.32% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -16.48%
    OGN annual earnings per share is down -16.48% year-on-year

    EPS Sector Percentile

    94.13%
    OGN annual earnings per share is higher than 94.13% of companies in Healthcare sector

    Profit

    Gross Profit

    $3.71B
    OGN annual gross profit is $3.71 billion

    Gross Margin

    58.02%
    OGN annual gross profit margin is 58.02%

    Operating Profit

    $1.50B
    OGN annual operating income is $1.50 billion

    Operating Margin

    -18.59%
    OGN annual operating profit margin is -18.59%

    Net Income

    $864.00M
    OGN annual net profit is $864.00 million

    Net Margin

    13.49%
    OGN annual net profit margin is 13.49%

    Expenses

    Total Expenses

    $5.54B
    OGN annual total expenses is $5.54 billion

    Operating Expenses

    $2.22B
    OGN annual total operating expenses is $2.22 billion

    Cost Of Goods Sold

    $2.69B
    OGN annual cost of goods sold is $2.69 billion

    Selling, General & Administrative Expenses

    $0.00
    OGN annual SG&A is $0.00

    Depreciation & Amortization

    $277.00M
    OGN annual D&A is $277.00 million

    Interest Expense

    $0.00
    OGN annual interest expense is $0.00

    Income Tax

    -$57.00M
    OGN annual income tax is -$57.00 million

    EBIT & EBITDA

    EBIT

    $1.50B
    OGN annual earnings before interest & taxes is $1.50 billion

    EBITDA

    $1.77B
    OGN annual EBITDA is $1.77 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $13.10B
    OGN annual total assets is $13.10 billion

    Non Current Assets

    $8.75B
    OGN annual long term assets is $8.75 billion

    Current Assets

    $4.35B
    OGN annual total current assets is $4.35 billion

    Cash and Cash Equivalents

    $675.00M
    OGN annual cash & cash equivalents is $675.00 million

    Accounts Receivable

    $1.36B
    OGN annual accounts receivable is $1.36 billion

    Inventory

    $1.32B
    OGN annual inventory is $1.32 billion

    Liabilities

    Total Liabilities

    $12.63B
    OGN annual total liabilities is $12.63 billion

    Long Term Liabilities

    $939.00M
    OGN annual total long term liabilities is $939.00 million

    Current Liabilities

    $2.72B
    OGN annual current liabilities is $2.72 billion

    Accounts Payable

    $1.15B
    OGN annual accounts payable is $1.15 billion

    Debt

    Total Debt

    $9.04B
    OGN annual total debt is $9.04 billion

    Total Debt 1-Year Change

    +1.18%
    OGN annual total debt is up +1.18% year-on-year

    Long Term Debt

    $8.97B
    OGN annual long term debt is $8.97 billion

    Short Term Debt

    $64.00M
    OGN annual short term debt is $64.00 million

    Equity & Capital

    Shareholders Equity

    $472.00M
    OGN annual stockholders equity is $472.00 million

    Book Value

    $472.00M
    OGN annual book value is $472.00 million

    Retained Earnings

    $1.01B
    OGN annual retained earnings is $1.01 billion

    Working Capital

    $1.63B
    OGN annual working capital is $1.63 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $939.00M
    OGN annual cash from operations is $939.00 million

    Cash From Operations 1-Year Change

    +17.52%
    OGN annual cash from operations is up +17.52% year-on-year

    Cash From Investing

    -$513.00M
    OGN annual cash from investing is -$513.00 million

    Cash From Investing 1-Year Change

    -97.31%
    OGN annual cash from investing is down -97.31% year-on-year

    Cash From Financing

    -$368.00M
    OGN annual cash from financing is -$368.00 million

    Cash From Financing 1-Year Change

    +35.33%
    OGN annual cash from financing is up +35.33% year-on-year

    CAPEX

    CAPEX

    $246.00M
    OGN annual capital expenditures is $246.00 million

    CAPEX 1-Year Change

    -5.02%
    OGN annual capital expenditures is down -5.02% year-on-year

    Free Cash Flow

    Free Cash Flow

    $693.00M
    OGN annual free cash flow is $693.00 million

    Free Cash Flow 1-Year Change

    +28.33%
    OGN annual free cash flow is up +28.33% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    58.02%
    OGN annual gross profit margin is 58.02%

    Operating Margin

    -18.59%
    OGN annual operating profit margin is -18.59%

    Net Margin

    13.49%
    OGN annual net profit margin is 13.49%

    ROA & ROE

    ROA

    6.87%
    OGN annual return on assets is 6.87%

    ROE

    429.85%
    OGN annual return on equity is 429.85%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    4.02
    OGN price to earnings ratio is 4.02

    PE Ratio Sector Percentile

    5.6%
    OGN price to earnings ratio is higher than 5.6% of companies in Healthcare sector

    PB Ratio

    PB Ratio

    2.22
    OGN price to book ratio is 2.22

    PB Ratio Sector Percentile

    53.58%
    OGN price to book ratio is higher than 53.58% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.32
    OGN price to sales ratio is 0.32

    PS Ratio Sector Percentile

    10.14%
    OGN price to sales ratio is higher than 10.14% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $10.17B
    OGN enterprise value is $10.17 billion

    Enterprise Value Sector Percentile

    91.28%
    OGN enterprise value is higher than 91.28% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    6.15
    OGN EV/EBITDA is 6.15

    EV/EBITDA Sector Percentile

    75.96%
    OGN EV/EBITDA is higher than 75.96% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.60
    OGN annual current ratio is 1.60

    Quick Ratio

    1.11
    OGN annual quick ratio is 1.11

    Leverage

    Debt To Equity

    19.14
    OGN annual debt to equity ratio is 19.14

    Interest Coverage Ratio

    -
    OGN annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    5
    OGN piotroski f-score is 5

    Altman Z-Score

    1.22
    OGN altman z-score is 1.22

    Analyst ratings

    Recent major analysts updates

    Nov 11, 25 Morgan Stanley
    Equal-Weight
    Nov 11, 25 JP Morgan
    Underweight
    May 15, 25 Piper Sandler
    Overweight
    May 5, 25 Morgan Stanley
    Equal-Weight
    Apr 9, 25 Morgan Stanley
    Equal-Weight
    Feb 14, 25 Morgan Stanley
    Equal-Weight
    Feb 14, 25 Barclays
    Overweight
    Sep 6, 24 JP Morgan
    Underweight
    May 6, 24 Goldman Sachs
    Neutral
    May 3, 24 Goldman Sachs
    Neutral

    Institutional Ownership

    Screeners with OGN included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    Stocks below analysts price target
    Healthcare sector
    Companies with growing dividends
    All stocks
    High-Yield Dividend Stocks
    • What is the ticker symbol for Organon & Co.?
    • Does Organon & Co. pay dividends?
    • What sector is Organon & Co. in?
    • What industry is Organon & Co. in?
    • What country is Organon & Co. based in?
    • When did Organon & Co. go public?
    • Is Organon & Co. in the S&P 500?
    • Is Organon & Co. in the NASDAQ 100?
    • Is Organon & Co. in the Dow Jones?
    • When was Organon & Co.'s last earnings report?
    • When does Organon & Co. report earnings?

    What is the ticker symbol for Organon & Co.?

    The ticker symbol for Organon & Co. is NYSE:OGN

    Does Organon & Co. pay dividends?

    Yes, Organon & Co. pays dividends. The last payment was $0.02, with an ex-dividend date on November 20, 2025

    What sector is Organon & Co. in?

    Organon & Co. is in the Healthcare sector

    What industry is Organon & Co. in?

    Organon & Co. is in the General Drug Manufacturers industry

    What country is Organon & Co. based in?

    Organon & Co. is headquartered in United States

    When did Organon & Co. go public?

    Organon & Co.'s initial public offering (IPO) was on May 14, 2021

    Is Organon & Co. in the S&P 500?

    No, Organon & Co. is not included in the S&P 500 index

    Is Organon & Co. in the NASDAQ 100?

    No, Organon & Co. is not included in the NASDAQ 100 index

    Is Organon & Co. in the Dow Jones?

    No, Organon & Co. is not included in the Dow Jones index

    When was Organon & Co.'s last earnings report?

    Organon & Co.'s most recent earnings report was on November 10, 2025

    When does Organon & Co. report earnings?

    The next expected earnings date for Organon & Co. is February 12, 2026
    On this page